Table 3 Moderators of the effectiveness of IM-CBT on psychiatric symptoms and physical distress (n = 44 studies).

From: Internet-based and mobile-based cognitive behavioral therapy for chronic diseases: a systematic review and meta-analysis

Moderator

Psychiatric symptoms

Physical distress

 

k

Statistic type

Statistic value (95% CI)

p

k

Statistic type

Statistic value (95% CI)

p

Model 1 Psychiatric symptoms

  Subgroup differences

Q-value

8.236

0.083

  Depressive symptoms

43

Hedge’s g

0.462 (0.323 to 0.601)

<0.001

  Anxiety symptoms

34

Hedge’s g

0.328 (0.199 to 0.456)

<0.001

  Depressive and anxiety symptoms

7

Hedge’s g

0.489 (–0.023 to 1.001)

0.061

  PTSD symptoms

3

Hedge’s g

0.904 (0.431 to 1.377)

<0.001

  General psychological distress

10

Hedge’s g

0.693 (0.297 to 1.090)

0.001

Model 2 Physical distress

  Subgroup differences

Q-value

3.320

0.345

  Physical symptoms

31

Hedge’s g

0.173 (0.076 to 0.271)

<0.001

  Functional impairment

21

Hedge’s g

0.282 (0.164 to 0.400)

<0.001

  Self-rated ill health

4

Hedge’s g

0.062 (–0.297 to 0.421)

0.735

  Objective physiological dysfunction

2

Hedge’s g

0.047 (–0.332 to 0.427)

0.807

Model 3 Gender

  Female percentage (28.81%–100.00%)

48

Coefficient

0.002 (–0.005 to 0.009)

0.521

36

Coefficient

0.003 (–0.002 to 0.008)

0.177

Model 4 Chronic disease

  Subgroup differences

Q-value

4.560

0.714

Q-value

2.927

0.892

  Chronic pain

21

Hedge’s g

0.391 (0.216 to 0.566)

<0.001

21

Hedge’s g

0.232 (0.111 to 0.353)

<0.001

  Cancer

9

Hedge’s g

0.495 (0.099 to 0.892)

0.014

4

Hedge’s g

0.162 (–0.046 to 0.370)

0.128

  Arthritis

6

Hedge’s g

0.402 (0.094 to 0.709)

0.010

5

Hedge’s g

0.165 (–0.042 to 0.373)

0.119

  Cardiovascular disease

4

Hedge’s g

0.504 (0.245 to 0.764)

<0.001

1

Hedge’s g

0.072 (–0.093 to 0.238)

0.391

  Diabetes

2

Hedge’s g

0.461 (–0.580 to 1.503)

0.385

1

Hedge’s g

0.024 (–0.427 to 0.475)

0.916

  Multiple sclerosis

1

Hedge’s g

0.641 (–0.240 to 1.523)

0.154

1

Hedge’s g

0.278 (–0.587 to 1.142)

0.529

  HIV

1

Hedge’s g

–0.200 (–0.906 to 0.506)

0.578

1

Hedge’s g

0.154 (–0.546 to 0.855)

0.666

  Different chronic diseases

4

Hedge’s g

0.566 (0.230 to 0.902)

0.001

2

Hedge’s g

–0.009 (–1.070 to 1.051)

0.986

Model 5 Physical or psychiatric comorbidity

  Subgroup differences

Q-value

0.033

0.857

Q-value

0.048

0.826

  Yes

24

Hedge’s g

0.441 (0.255 to 0.628)

<0.001

16

Hedge’s g

0.171 (0.049 to 0.293)

0.006

  No

24

Hedge’s g

0.419 (0.264 to 0.573)

<0.001

20

Hedge’s g

0.190 (0.070 to 0.309)

0.002

Model 6 Medication received for physical condition(s)

  Subgroup differences

Q-value

0.114

0.735

Q-value

0.089

0.766

  Yes

25

Hedge’s g

0.400 (0.234 to 0.647)

<0.001

18

Hedge’s g

0.195 (0.077 to 0.314)

0.001

  No

23

Hedge’s g

0.400 (0.283 to 0.517)

<0.001

18

Hedge’s g

0.170 (0.046 to 0.293)

0.007

Model 7 Surgery received for physical condition(s)

  Subgroup differences

Q-value

0.268

0.605

Q-value

0.367

0.545

  Yes

8

Hedge’s g

0.537 (0.069 to 1.005)

0.024

4

Hedge’s g

0.095 (–0.201 to 0.391)

0.530

  No

40

Hedge’s g

0.410 (0.291 to 0.529)

<0.001

32

Hedge’s g

0.191 (0.102 to 0.279)

<0.001

Model 8 Supplement and/or other received for physical condition(s)

  Subgroup differences

Q-value

0.090

0.764

Q-value

0.040

0.841

  Yes

6

Hedge’s g

0.478 (0.094 to 0.862)

0.015

6

Hedge’s g

0.197 (–0.072 to 0.466)

0.151

  No

42

Hedge’s g

0.416 (0.290 to 0.543)

<0.001

30

Hedge’s g

0.168 (0.082 to 0.254)

<0.001

Model 9 Medication received for psychiatric condition(s)

  Subgroup differences

Q-value

3.099

0.078

Q-value

1.478

0.224

  Yes

13

Hedge’s g

0.641 (0.300 to 0.982)

<0.001

8

Hedge’s g

0.296 (0.055 to 0.536)

0.016

  No

35

Hedge’s g

0.323 (0.224 to 0.421)

<0.001

28

Hedge’s g

0.139 (0.061 to 0.216)

<0.001

Model 10 Psychotherapy (non-CBT) received for psychiatric condition(s)

  Subgroup differences

Q-value

0.683

0.408

Q-value

0.476

0.490

  Yes

3

Hedge’s g

0.893 (–0.280 to 2.066)

0.136

1

Hedge’s g

0.024 (–0.427 to 0.475)

0.916

  No

45

Hedge’s g

0.396 (0.289 to 0.503)

<0.001

35

Hedge’s g

0.186 (0.100 to 0.272)

<0.001

Model 11 Main intervention delivery format

  Subgroup differences

Q-value

4.030

0.133

Q-value

0.063

0.969

  Videoconference

3

Hedge’s g

–0.013 (–0.445 to 0.419)

0.953

3

Hedge’s g

0.254 (–0.340 to 0.847)

0.402

  Web-based

42

Hedge’s g

0.448 (0.321 to 0.576)

<0.001

32

Hedge’s g

0.180 (0.093 to 0.267)

<0.001

  Mobile app

3

Hedge’s g

0.403 (–0.272 to 1.077)

0.242

1

Hedge’s g

0.154 (–0.546 to 0.855)

0.666

Model 12 Guidance

  Subgroup differences

Q-value

0.055

0.814

Q-value

0.452

0.501

  Guided

33

Hedge’s g

0.434 (0.284 to 0.584)

<0.001

25

Hedge’s g

0.205 (0.099 to 0.311)

<0.001

  Unguided

15

Hedge’s g

0.404 (0.204 to 0.603)

<0.001

11

Hedge’s g

0.144 (0.004 to 0.285)

0.044

Model 13 Intervention length (no. of sessions)

  Subgroup differences

Q-value

6.772

0.009

Q-value

1.685

0.194

  Medium/long (≥12 sessions)

10

Hedge’s g

0.186 (0.014 to 0.358)

0.034

7

Hedge’s g

0.082 (–0.088 to 0.252)

0.343

  Short (<12 sessions)

38

Hedge’s g

0.481 (0.341 to 0.621)

<0.001

29

Hedge’s g

0.211 (0.116 to 0.307)

<0.001

Model 14 Intervention duration (weeks)

  Duration in weeks (4–26 weeks)

48

Coefficient

0.005 (–0.021 to 0.032)

0.697

36

Coefficient

0.005 (–0.010 to 0.019)

0.530

Model 15 Intervention session number

  Session number (4–48 sessions)

48

Coefficient

–0.001 (–0.018 to 0.015)

0.885

36

Coefficient

–0.021 (–0.039 to –0.002)

0.034

Model 16 Intervention frequency

  Sessions per week (0.15–4.80)

48

Coefficient

–0.044 (–0.207 to 0.119)

0.597

36

Coefficient

–0.237 (–0.387 to –0.087)

0.002

Model 17 Total number of therapeutic elements

  Number of components (2–5)

48

Coefficient

0.063 (–0.087 to 0.213)

0.407

36

Coefficient

0.032 (–0.061 to 0.125)

0.501

Model 18 Intervention has behavioral modification element

  Subgroup differences

Q-value

19.498

<0.001

Q-value

  Yes

47

Hedge’s g

0.442 (0.322 to 0.561)

<0.001

36

Hedge’s g

0.181 (0.097 to 0.265)

<0.001

  No

1

Hedge’s g

–0.045 (–0.225 to 0.135)

0.624

Hedge’s g

Model 19 Intervention has cognitive restructuring element

  Subgroup differences

Q-value

0.486

0.486

Q-value

2.016

0.156

  Yes

34

Hedge’s g

0.454 (0.298 to 0.610)

<0.001

27

Hedge’s g

0.212 (0.110 to 0.313)

<0.001

  No

14

Hedge’s g

0.373 (0.208 to 0.539)

<0.001

9

Hedge’s g

0.078 (–0.075 to 0.232)

0.318

Model 20 Intervention has problem-solving element

  Subgroup differences

Q-value

1.508

0.220

Q-value

3.714

0.054

  Yes

47

Hedge’s g

0.433 (0.311 to 0.556)

<0.001

35

Hedge’s g

0.170 (0.088 to 0.251)

<0.001

  No

1

Hedge’s g

0.066 (–0.509 to 0.640)

0.823

1

Hedge’s g

0.765 (0.165 to 1.366)

0.012

Model 21 Intervention has psychoeducation element

  Subgroup differences

Q-value

0.873

0.350

Q-value

0.034

0.854

  Yes

41

Hedge’s g

0.404 (0.271 to 0.537)

<0.001

31

Hedge’s g

0.176 (0.099 to 0.253)

<0.001

  No

7

Hedge’s g

0.554 (0.269 to 0.840)

<0.001

5

Hedge’s g

0.213 (–0.179 to 0.605)

0.286

Model 22 Intervention has mindfulness element

  Subgroup differences

Q-value

0.647

0.421

Q-value

0.245

0.621

  Yes

31

Hedge’s g

0.460 (0.305 to 0.614)

<0.001

24

Hedge’s g

0.173 (0.094 to 0.252)

<0.001

  No

17

Hedge’s g

0.357 (0.162 to 0.553)

<0.001

12

Hedge’s g

0.116 (–0.097 to 0.328)

0.286

Model 23 Measurement timepoint

  Subgroup differences

Q-value

0.976

0.614

Q-value

2.260

0.323

  Last follow-up (12–48 weeks)

6

Hedge’s g

0.431 (0.258 to 0.605)

<0.001

4

Hedge’s g

0.088 (–0.071 to 0.246)

0.278

  First follow-up (8–36 weeks)

21

Hedge’s g

0.328 (0.176 to 0.480)

<0.001

17

Hedge’s g

0.075 (–0.858 to 0.391)

0.391

  Post-intervention

48

Hedge’s g

0.411 (0.288 to 0.534)

<0.001

36

Hedge’s g

0.185 (0.118 to 0.252)

<0.001

Model 24 Follow-up duration after intervention (weeks)

  Duration in weeks (8–48 weeks)

27

Coefficient

–0.002 (–0.012 to 0.009)

0.745

21

Coefficient

–0.003 (–0.014 to 0.007)

0.560

Model 25 Control group type

  Subgroup differences

Q-value

3.941

0.047

Q-value

6.177

0.013

  Active

22

Hedge’s g

0.299 (0.160 to 0.437)

<0.001

13

Hedge’s g

0.049 (–0.064 to 0.163)

0.394

  Non-active

26

Hedge’s g

0.535 (0.347 to 0.723)

<0.001

23

Hedge’s g

0.243 (0.141 to 0.346)

<0.001

Model 26 Overall risk of bias

  Subgroup differences

Q-value

3.855

0.146

Q-value

0.274

0.872

  High risk

19

Hedge’s g

0.306 (0.145 to 0.467)

<0.001

15

Hedge’s g

0.159 (0.047 to 0.270)

0.005

  Some concerns

26

Hedge’s g

0.530 (0.327 to 0.732)

<0.001

17

Hedge’s g

0.211 (0.048 to 0.375)

0.011

  Low risk

3

Hedge’s g

0.301 (0.170 to 0.431)

<0.001

4

Hedge’s g

0.177 (–0.013 to 0.367)

0.068

Model 27 Attrition rate at post-intervention

  Subgroup differences

Q-value

1.223

0.543

Q-value

2.199

0.333

  High (>20%)

8

Hedge’s g

0.424 (0.130 to 0.717)

0.005

5

Hedge’s g

0.068 (–0.136 to 0.271)

0.517

  Moderate (5–20%)

34

Hedge’s g

0.443 (0.284 to 0.602)

<0.001

25

Hedge’s g

0.177 (0.065 to 0.288)

0.002

  Low (<5%)

6

Hedge’s g

0.308 (0.123 to 0.494)

0.001

6

Hedge’s g

0.274 (0.092 to 0.457)

0.003

Model 28 Intention-to-treat analysis

  Subgroup differences

Q-value

0.242

0.623

Q-value

0.321

0.571

  Yes

36

Hedge’s g

0.439 (0.294 to 0.583)

<0.001

28

Hedge’s g

0.181 (0.106 to 0.255)

<0.001

  No

12

Hedge’s g

0.377 (0.178 to 0.576)

<0.001

8

Hedge’s g

0.091 (–0.209 to 0.392)

0.552

  1. k = Number of averaged effect sizes (to address the potential dependency issues, when multiple effect sizes were available from the same source, the moderator analyses were done based on the averaged effect sizes). The moderator analysis for “Follow-up duration after intervention” was only analyzed upon follow-up data points. A table presenting moderator analyses for n = 58 studies (including 44 studies here and another 14 studies included in the Supplementary Information only) is available in Supplementary Table 9.
  2. Definitions. “Guidance” was defined as: “Guided” refers to therapists’ therapeutic input, including active provision of intervention, feedback, and/or support; “Unguided” refers to technical/adherence or other non-specified assistance only12. “Intervention duration” was defined as: <12 sessions = short, 12–16 sessions = medium, >16 sessions = long19. “Non-active” control group included waitlist control (WLC) and treatment-as-usual (TAU) / standard care (SC); “Active” control group included information/education (k = 10), discussion forum (k = 5), relaxation (k = 2), attention control (scheduled contact) (k = 2), supportive therapy (k = 1), computerized cognitive remediation therapy (k = 1), and lifestyle management (k = 1). “Attrition rate at post-intervention” was defined as: <5% = low, 5–20% = moderate, and >20% = high106.